Calliditas Therapeutics AB (CALT) Stock Cash Flow
NASDAQ:CALT - Nasdaq - US13124Q1067 - ADR - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -353.14M | -373.06M | -421.94M | -524.46M | -379.72M | |||
| Depreciation Amortization | N/A | 48.73M | 12.91M | N/A | N/A | |||
| Change In Working Capital | -86.42M | -164.08M | 49.33M | -3.81M | 55.07M | |||
| Interest Paid | 112.40M | 94.50M | 35.25M | 5.43M | 393.00K | |||
| Taxes Paid | 25.25M | 22.75M | 7.39M | 3.95M | 528.00K | |||
| Other non cash items | 194.63M | 53.75M | 48.35M | 66.68M | 15.46M | |||
| OPERATING CASH FLOW | -244.93M | -434.65M | -311.35M | -461.59M | -309.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -12.79M | -2.51M | -22.65M | N/A | |||
| Other Investing Activity | -13.73M | -957.00K | -2.63M | -1.69M | -172.61M | |||
| INVESTING CASH FLOW | -13.73M | -13.74M | -5.14M | -24.34M | -172.61M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 196.11M | 199.65M | 480.87M | 179.09M | -3.97M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 95.12M | 324.00M | 950.64M | |||
| Other Financing Activity | N/A | -1.00K | -1.00K | -67.93M | -178.11M | |||
| FINANCING CASH FLOW | 196.12M | 199.65M | 575.99M | 435.16M | 768.56M | |||
| Exchange Rate Effect | -6.36M | -26.61M | 34.09M | 9.97M | -44.01M | |||
| CHANGE IN CASH | -68.90M | -275.36M | 293.59M | -40.80M | 242.76M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -244.93M | -434.65M | -311.35M | -461.59M | -309.18M | |||
| Capital Expenditure | N/A | -12.79M | -2.51M | -22.65M | N/A | |||
| FREE CASH FLOW | -244.93M | -447.44M | -313.87M | -484.24M | -309.18M | |||
All data in SEK